Annual Cash & Cash Equivalents
$230.78 M
+$145.52 M+170.68%
31 December 2023
Summary:
Day One Biopharmaceuticals annual cash & cash equivalents is currently $230.78 million, with the most recent change of +$145.52 million (+170.68%) on 31 December 2023. During the last 3 years, it has risen by +$187.06 million (+427.77%). DAWN annual cash & cash equivalents is now -18.83% below its all-time high of $284.31 million, reached on 31 December 2021.DAWN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$422.76 M
+$183.15 M+76.43%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly cash and cash equivalents is currently $422.76 million, with the most recent change of +$183.15 million (+76.43%) on 30 September 2024. Over the past year, it has increased by +$181.59 million (+75.29%). DAWN quarterly cash and cash equivalents is now at all-time high.DAWN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +170.7% | +75.3% |
| 3 y3 years | +427.8% | +42.3% |
| 5 y5 years | - | - |
DAWN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.8% | +427.8% | at high | +758.1% |
| 5 y | 5 years | -18.8% | +744.4% | at high | +866.8% |
| alltime | all time | -18.8% | +744.4% | at high | +866.8% |
Day One Biopharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $422.76 M(+76.4%) |
| June 2024 | - | $239.62 M(-11.4%) |
| Mar 2024 | - | $270.39 M(+17.2%) |
| Dec 2023 | $230.78 M(+170.7%) | $230.78 M(-4.3%) |
| Sept 2023 | - | $241.18 M(+27.5%) |
| June 2023 | - | $189.21 M(+284.0%) |
| Mar 2023 | - | $49.27 M(-42.2%) |
| Dec 2022 | $85.26 M | $85.26 M(-29.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $120.86 M(-68.9%) |
| June 2022 | - | $388.88 M(+48.0%) |
| Mar 2022 | - | $262.73 M(-7.6%) |
| Dec 2021 | $284.31 M(+550.2%) | $284.31 M(-4.3%) |
| Sept 2021 | - | $297.16 M(-4.1%) |
| June 2021 | - | $310.00 M(+100.2%) |
| Mar 2021 | - | $154.87 M(+254.2%) |
| Dec 2020 | $43.73 M(+60.0%) | $43.73 M |
| Dec 2019 | $27.33 M | - |
FAQ
- What is Day One Biopharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Day One Biopharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Day One Biopharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of DAWN is $230.78 M
What is the all time high annual cash & cash equivalents for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual cash & cash equivalents is $284.31 M
What is Day One Biopharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, DAWN annual cash & cash equivalents has changed by +$145.52 M (+170.68%)
What is Day One Biopharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DAWN is $422.76 M
What is the all time high quarterly cash and cash equivalents for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly cash and cash equivalents is $422.76 M
What is Day One Biopharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, DAWN quarterly cash and cash equivalents has changed by +$181.59 M (+75.29%)